Compare
Leef Brands Inc. vs Cyanotech Corp vs Mannatech Inc vs Niagen Bioscience, Inc.
| Latest fiscal year | Leef Brands Inc. LEEEF | Cyanotech Corp CYANLast annual report: year ended 2025-03-31 | Mannatech Inc MTEX | Niagen Bioscience, Inc. NAGE |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-03-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $34.79M | $24.21M | $108.04M | $129.42M |
| Revenue growth (YoY) | +22.1% | +5.0% | -8.3% | +29.9% |
| Gross margin | 30.1% | 28.4% | 74.9% | 64.3% |
| Operating margin | -21.8% | -10.4% | -0.4% | 12.6% |
| Net margin | -50.7% | -13.2% | -14.1% | 13.4% |
| Net income | -$17.63M | -$3.20M | -$15.21M | $17.38M |
| EPS (Diluted) | -$0.10 | n/a | -$8.00 | $0.20 |
| Operating cash flow | -$336.9K | -$1.19M | -$2.96M | $13.50M |
| Free cash flow | -$978.9K | n/a | -$4.32M | n/a |
| Cash & equivalents | $2.19M | $257.0K | $6.18M | n/a |
| Total assets | $36.40M | $23.49M | $29.99M | $106.41M |
| Total liabilities | $44.67M | $14.61M | $35.22M | $29.87M |
| Shareholders' equity | -$8.27M | $8.88M | -$5.22M | $76.53M |
| Return on year-end equity | n/a | -36.1% | n/a | 22.7% |
| Shares outstanding | 257.95M | 7.20M | 1.90M | 79.71M |
Revenue, most recent five fiscal years
| Fiscal year | Leef Brands Inc. | Cyanotech Corp | Mannatech Inc | Niagen Bioscience, Inc. |
|---|---|---|---|---|
| Latest | $34.79M Ended 2025-12-31 | $24.21M Ended 2025-03-31 | $108.04M Ended 2025-12-31 | $129.42M Ended 2025-12-31 |
| 1 year earlier | $28.50M Ended 2024-12-31 | $23.07M Ended 2024-03-31 | $117.87M Ended 2024-12-31 | $99.60M Ended 2024-12-31 |
| 2 years earlier | n/a | $23.18M Ended 2023-03-31 | $131.96M Ended 2023-12-31 | $83.57M Ended 2023-12-31 |
| 3 years earlier | n/a | $35.97M Ended 2022-03-31 | $137.21M Ended 2022-12-31 | $72.05M Ended 2022-12-31 |
| 4 years earlier | n/a | $32.34M Ended 2021-03-31 | $159.76M Ended 2021-12-31 | $67.45M Ended 2021-12-31 |